EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1

Calixto-Hope G Lucas iD, Andrea M Gross iD, Carlos G Romo, Carina A Dehner, Alexander J Lazar iD, Markku Miettinen, Melike Pekmezci, Martha Quezado, Fausto J Rodriguez, Anat Stemmer-Rachamimov, David Viskochil, Arie Perry und 1 weitere

Neuro-Oncology · 07.03.2025 · 27 (3) · 616-624

DOI: 10.1093/neuonc/noae235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 06.11.2024. Verfasst von Calixto-Hope G Lucas und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Neurofibromatosis 1, Nerve Sheath Neoplasms. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Consensus recommendations published in 2017 histologically defining atypical neurofibromatous neoplasm of uncertain biologic potential (ANNUBP) and malignant peripheral nerve sheath tumor (MPNST) were codified in the 2021 WHO Classification of Tumors of the Central Nervous System and the 2022 WHO Classification of Tumors of Soft Tissue and Bone. However, given the shift in diagnostic pathology toward the use of integrated histopathologic and genomic approaches, the incorporation of additional molecular strata in the classification of Neurofibromatosis Type 1 (NF1)-associated peripheral nerve sheath tumors should be formalized to aid in accurate diagnosis and early identification of malignant transformation and enable appropriate intervention for affected patients. To this end, we assembled a multi-institutional expert pathology working group as part of a “Symposium on Atypical Neurofibroma: State of the Science.” Herein, we provide a suggested framework for adequate interventional radiology and surgical sampling and recommend molecular profiling for clinically or radiologically worrisome noncutaneous lesions in patients with NF1 to identify diagnostically-relevant molecular features, including CDKN2A/B inactivation for ANNUBP, as well as SUZ12, EED, or TP53 inactivating mutations, or significant aneuploidy for MPNST. We also propose renaming “low-grade MPNST” to “ANNUBP with increased proliferation” to avoid the use of the “malignant” term in this group of tumors with persistent unknown biologic potential. This refined integrated diagnostic approach for NF1-associated peripheral nerve sheath tumors should continue to evolve in concert with our understanding of these neoplasms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurofibromatosis 1Nerve Sheath NeoplasmsHumansBiomarkers, Tumor

Stichwörter der Autor:innen

consensusguidelinesmolecular neuropathologynerve sheath tumorneurofibromatosis type 1

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Calixto-Hope G Lucas, Andrea M Gross, Alexander J Lazar

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health
  • National Cancer Institute

Zitieren

APA

Lucas, C. G., Gross, A. M., Romo, C. G., Dehner, C. A., Lazar, A. J., Miettinen, M., Pekmezci, M., Quezado, M., Rodriguez, F. J., Stemmer-Rachamimov, A., Viskochil, D., Perry, A., & Symposium on Atypical Neurofibroma: State of the Science Members (2025). Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1. Neuro-Oncology, 27(3), 616-624. https://doi.org/10.1093/neuonc/noae235

Vancouver

Lucas CG, Gross AM, Romo CG, Dehner CA, Lazar AJ, Miettinen M, et al. Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1. Neuro-Oncology. 2025;27(3):616-624. doi:10.1093/neuonc/noae235

BibTeX
@article{Lucas2025,
  author = {Lucas, Calixto-Hope G and Gross, Andrea M and Romo, Carlos G and Dehner, Carina A and Lazar, Alexander J and Miettinen, Markku and Pekmezci, Melike and Quezado, Martha and Rodriguez, Fausto J and Stemmer-Rachamimov, Anat and Viskochil, David and Perry, Arie and Symposium on Atypical Neurofibroma: State of the Science Members, Symposium on Atypical Neurofibroma: State of the Science Members},
  title = {Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1},
  journal = {Neuro-Oncology},
  year = {2025},
  volume = {27},
  number = {3},
  pages = {616--624},
  doi = {10.1093/neuonc/noae235}
}
Kostenlos starten →